Citation Impact
Citing Papers
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
The EPIC Kids Study: a randomized family-focused YMCA-based intervention to prevent type 2 diabetes in at-risk youth
2015
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
2016
Genetic determinants of hepatic steatosis in man
2011
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
2017
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
2013
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Inflammatory links between obesity and metabolic disease
2011 Standout
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
2015
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
2016
Effectiveness of an implementation optimisation intervention aimed at increasing parent engagement in HENRY, a childhood obesity prevention programme - the Optimising Family Engagement in HENRY (OFTEN) trial: study protocol for a randomised controlled trial
2017
Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake
2012
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
2012 Nature
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis
2011
The Ethics of Childhood Obesity Treatment - from the Childhood Obesity Task Force (COTF) of European Association for the Study of Obesity (EASO)
2014
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
2022
The prenatal origins of lung cancer. I. The fetus
2010
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
What causes the insulin resistance underlying obesity?
2012
RBP4: a controversial adipokine
2011
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
2015
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
2010
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
The genetics of NAFLD
2013
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Genistein Reduces Hyperglycemia and Islet Cell Loss in a High-Dosage Manner in Rats With Alloxan-Induced Pancreatic Damage
2011
Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches
2013
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
2011
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role
2011
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease
2012
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
2011
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
The global NAFLD epidemic
2013 Standout
Characterizing the profile of obese patients who are metabolically healthy
2010
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Type 2 diabetes mellitus
2015 Standout
Macrophage M1/M2 polarization
2020 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Molecular aspects of fructose metabolism and metabolic disease
2021
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
NAFLD: A multisystem disease
2015 Standout
Management of metabolic syndrome in children and adolescents
2011
Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis
2015
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
2017
Ethnic differences regarding arterial stiffness of 6‐8‐year-old black and white boys
2017
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Childhood Disadvantage and Health Problems in Middle and Later Life
2015 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
2013
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
2015
Vitamin E Inadequacy in Humans: Causes and Consequences
2014
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance
2015
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Effect of 8 Weeks of Overfeeding on Ectopic Fat Deposition and Insulin Sensitivity: Testing the “Adipose Tissue Expandability” Hypothesis
2014
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Hypoglycemic agents and potential anti-inflammatory activity
2016
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
2021
Interventions for preventing obesity in children
2019 Standout
β-Cell Function, Incretin Effect, and Incretin Hormones in Obese Youth Along the Span of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes
2014
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
2015
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice
2016
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Targeting fatty acid metabolism to improve glucose metabolism
2015
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
2015
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
2014
Works of Ebe D’Adamo being referenced
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study
2015
The possible role of liver steatosis in defining metabolic syndrome in prepubertal children
2009
A Common Variant in the Patatin-Like Phospholipase 3 Gene ( PNPLA3 ) Is Associated with Fatty Liver Disease in Obese Children and Adolescents
2010
Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
2009
Liver Steatosis in Obese Prepubertal Children: A Possible Role of Insulin Resistance
2008
Could Receptors for Advanced Glycation End Products Be Considered Cardiovascular Risk Markers in Obese Children?
2012
What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?
2010
High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation
2010
Cellularity and Adipogenic Profile of the Abdominal Subcutaneous Adipose Tissue From Obese Adolescents: Association With Insulin Resistance and Hepatic Steatosis
2010
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
2011
Insulin Resistance and Oxidative Stress in Children Born Small and Large for Gestational Age
2009
Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E
2012
Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
2012
Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese Adolescents
2010
Basal α-Cell Up-Regulation in Obese Insulin-Resistant Adolescents
2010
Decreased Transcription of ChREBP-α/β Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes
2012